166 related articles for article (PubMed ID: 36779819)
1. The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists.
Berger JJ; Fitzgerald PB
Australas Psychiatry; 2023 Apr; 31(2):190-194. PubMed ID: 36779819
[TBL] [Abstract][Full Text] [Related]
2. Re The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists.
Mellsop G; Ellis P
Australas Psychiatry; 2023 Oct; 31(5):706. PubMed ID: 37395611
[No Abstract] [Full Text] [Related]
3. A survey of Australian psychiatrists' and psychiatry trainees' knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders.
Grover C; Monds L; Montebello M
Australas Psychiatry; 2023 Jun; 31(3):329-335. PubMed ID: 36753675
[TBL] [Abstract][Full Text] [Related]
4. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
Barber GS; Dike CC
Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
[TBL] [Abstract][Full Text] [Related]
5. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
Barnett BS; Beaussant Y; King F; Doblin R
J Psychoactive Drugs; 2022; 54(3):269-277. PubMed ID: 34409921
[TBL] [Abstract][Full Text] [Related]
6. [Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].
Olafsson RP; Kvaran K; Ketilsdottir K; Hallgrimsdottir K; Sigurdsson EL; Sigurdsson E
Laeknabladid; 2023 Nov; 109(11):495-503. PubMed ID: 37909445
[TBL] [Abstract][Full Text] [Related]
7. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
Barnett BS; Greer GR
J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
[TBL] [Abstract][Full Text] [Related]
8. Psychedelic-assisted therapies: The past, and the need to move forward responsibly.
Gardner J; Carter A; O'Brien K; Seear K
Int J Drug Policy; 2019 Aug; 70():94-98. PubMed ID: 31136924
[TBL] [Abstract][Full Text] [Related]
9. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.
Holoyda B
Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796
[TBL] [Abstract][Full Text] [Related]
10. Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.
Davis AK; Agin-Liebes G; España M; Pilecki B; Luoma J
J Psychoactive Drugs; 2022; 54(4):309-318. PubMed ID: 34468293
[TBL] [Abstract][Full Text] [Related]
11. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics.
Kucsera A; Suppes T; Haug NA
Clin Psychol Psychother; 2023; 30(6):1369-1379. PubMed ID: 37394242
[TBL] [Abstract][Full Text] [Related]
12. Attitudes of European psychiatrists on psychedelics: a qualitative study.
Žuljević MF; Breški N; Kaliterna M; Hren D
Front Psychiatry; 2024; 15():1411234. PubMed ID: 38855648
[TBL] [Abstract][Full Text] [Related]
13. Access to healthcare by psychiatrists, psychiatric trainees and overseas trained psychiatrists: findings from the RANZCP welfare study.
Jenkins K
Australas Psychiatry; 2017 Apr; 25(2):175-177. PubMed ID: 28068827
[TBL] [Abstract][Full Text] [Related]
14. Medical student attitudes and perceptions of psychedelic-assisted therapies.
Li I; Fong R; Hagen M; Tabaac B
Front Psychiatry; 2023; 14():1190507. PubMed ID: 37441143
[TBL] [Abstract][Full Text] [Related]
15. UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.
Song-Smith C; Jacobs E; Rucker J; Saint M; Cooke J; Schlosser M
BMJ Open; 2024 Mar; 14(3):e083595. PubMed ID: 38485474
[TBL] [Abstract][Full Text] [Related]
16. The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy.
Page LA; Rehman A; Syed H; Forcer K; Campbell G
Front Psychiatry; 2021; 12():743599. PubMed ID: 35756728
[No Abstract] [Full Text] [Related]
17. Trainees Unprepared for Advances in Psychedelic Medicine: A Survey Study.
Geller J; Glynos N; Lemmen A; Pacilio R; Kruger DJ; Hosanagar A
J Psychoactive Drugs; 2024 Apr; ():1-8. PubMed ID: 38627929
[TBL] [Abstract][Full Text] [Related]
18. Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.
Corrigan K; Haran M; McCandliss C; McManus R; Cleary S; Trant R; Kelly Y; Ledden K; Rush G; O'Keane V; Kelly JR
Ir J Med Sci; 2022 Jun; 191(3):1385-1397. PubMed ID: 34131812
[TBL] [Abstract][Full Text] [Related]
19. An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.
Kruger DJ; Glynos NG; Fields CW; Herberholz M; Boehnke KF
J Psychoactive Drugs; 2023; 55(4):420-424. PubMed ID: 36328419
[TBL] [Abstract][Full Text] [Related]
20. Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.
Perkins D; Sarris J; Rossell S; Bonomo Y; Forbes D; Davey C; Hoyer D; Loo C; Murray G; Hood S; Schubert V; Galvão-Coelho NL; O'Donnell M; Carter O; Liknaitzky P; Williams M; Siskind D; Penington D; Berk M; Castle D
Aust N Z J Psychiatry; 2021 Dec; 55(12):1127-1133. PubMed ID: 33745287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
